INCY
Incyte Corporation · Healthcare
President, Global Head of R&D Pablo J Cagnoni sold $1.3M of Incyte Corporation
Sold$1,296,792
$120.04Price
10,803Shares
−5%Stake
What INCY did after the filing
- The stock from Tue, Aug 18 open, $124.29
- −2.4%
- S&P 500, same days
- −0.8%
Measured over 30 trading days, to the Sep 30 close.
Traded Wed, Aug 12. Filed Fri, Aug 14, 4:01 PM ET, after the close. Returns use the Aug 18 open and the Sep 30 close. Not investment advice.